Blood cyclosporin concentrations and renal allograft dysfunction.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1342192)

Published in Br Med J (Clin Res Ed) on November 29, 1986

Authors

S F Lui, Z Varghese, P Sweny, O N Fernando, J F Moorhead

Articles by these authors

A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55

Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med (1966) 2.91

A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26

Factors associated with active systemic lupus erythematosus after endstage renal disease. J Rheumatol (1998) 2.15

Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07

Long-term outcome of peritoneal dialysis in infants. J Pediatr (2000) 2.01

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98

Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol (1967) 1.96

Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int (2001) 1.71

Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71

The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med (2001) 1.62

Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60

Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59

Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation (2002) 1.58

Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med (1991) 1.56

SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis (2004) 1.53

Cancer in patients receiving dialysis. Br Med J (1980) 1.52

Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis (1999) 1.49

The polyneuropathy of chronic renal failure. Brain (1971) 1.49

Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet (1976) 1.47

Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol (1993) 1.46

Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45

Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41

Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39

Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38

Adverse interaction between warfarin and indomethacin. Drug Saf (1994) 1.38

Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet (1972) 1.36

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35

Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35

Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients. Kidney Int (2000) 1.33

Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis (2000) 1.31

Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int (2001) 1.29

Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 1.26

Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25

Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23

Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) (1983) 1.22

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut (1978) 1.19

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant (2008) 1.19

Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). J Med Virol (1999) 1.19

Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16

Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int (1981) 1.15

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol (1997) 1.15

Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.13

Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis (2001) 1.11

Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature (1969) 1.11

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11

Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med (1966) 1.11

Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol (2001) 1.09

Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09

Home dialysis in children and adolescents. Proc Eur Dial Transplant Assoc (1972) 1.09

Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc (1973) 1.04

Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation (2000) 1.03

Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet (1976) 1.03

Efficiency of scintillation counting of tritium labelled DNA-protein in the mixed leucocyte reaction in vitro. Nature (1966) 1.02

Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (2001) 1.01

Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol (1992) 1.00

Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia. Br Med J (1978) 0.99

Disorders of blood-lipids in renal disease. Lancet (1975) 0.99

Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis (2000) 0.99

Renal physiology revisited: amiloride. Lancet (1986) 0.98

Rejection encephalopathy. Proc Eur Dial Transplant Assoc (1981) 0.98

Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed) (1981) 0.97

Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) (1988) 0.97

The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts. Clin Exp Immunol (1982) 0.96

Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant (1988) 0.96